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Evaluation of in vitro wound healing efficacy of breadfruit derived starch 
hydrolysate 
Abstract
To study the wound healing efficacy of breadfruit starch hydrolysate, an in vitro wound 
scratch assay was conducted, in which the migration rate of wounded NIH 3T3 fibroblasts 
was determined. Wounds treated with lower dextrose equivalent (DE), (DE 10-14) starch 
hydrolysate were found capable to improve the wound healing of NIH 3T3 fibroblast cell 
with the percentage of wound closure improvement of 77%, respectively when compared with 
higher DE range (DE 15-19 and DE 20-24). The findings obtained in the BrdU uptake and 
MTT viability assays confirmed the wound healing properties of breadfruit starch hydrolysate 
as the starch hydrolysate-treated wounded NIH 3T3 fibroblasts were able to proliferate well 
and no cytotoxicity was observed. Together, these findings indicated that the newly developed 
breadfruit starch hydrolysate performed better than commercial (COM) starch hydrolysate 
of the same DE ranges. In conclusion, breadfruit starch hydrolysate had better functional 
properties than did starch hydrolysates derived from other sources and that they could play a 
beneficial role in wound healing applications.
Introduction
Breadfruit (Artocarpus atlitis) is a starchy staple 
when mature and rich in nutrients. It is a high-energy 
food with a moderate glycemic index (Zerega et al., 
2004). Breadfruit is found throughout the tropics 
and is cultivated on most Pacific islands (Zerega 
et al., 2004). In a study conducted by Gbadamosi 
and Oladeji (2013), the suitability of starches from 
carbohydrate-rich sources, including breadfruit, as 
a substitute for cassava starch was studied. Based 
on their results, breadfruit and cassava starch were 
closely related in terms of chemical composition and 
physico-functional properties, which made breadfruit 
starch a potential substitute for cassava starch. This 
study confirmed that breadfruit is a high-potential 
source for maltodextrin production because it is a 
carbohydrate-rich crop.
Starch hydrolysate is a product of starch 
hydrolysis that is produced via acid or enzymatic 
treatment. This product contains both simple sugars 
and polymers of saccharides with lower molecular-
weights. Starch hydrolysate is a white hygroscopic 
powder occurring as different grades that are 
categorized according to their dextrose equivalent 
(DE) value, which is a measure of the reducing power 
of dextrose compared with that of D-glucose on a dry-
weight basis (Wang et al., 2000). Starch hydrolysate 
has been widely used as an ingredient in various 
food products and pharmaceutical delivery systems. 
Previous finding has reported that starch hydrolysate 
may possess wound healing potential by promoting 
the proliferation of fibroblasts cell (Swaim, 1998).
The process of wound healing is complex, 
and good healing is characterized by the rapid 
regeneration of the damaged tissue. Wound healing 
involves the adequate interaction of cells and 
keratinocytes. Both fibroblasts and endothelial cells 
that perform cell biological functions are relevant 
to the process of wound healing. One of the most 
important aspects of this complex biological process 
is the epithelial closure, which relies primarily on 
the concerted action of activated keratinocytes and 






NIH 3T3 cell line
Article history
Received: 1 July 2016
Received in revised form: 
3 August 2016
Accepted: 3 August 2016
1772 Amin et al./IFRJ 24(4): 1771-1781
heal, newly regenerated cells fill in the gap of the 
wound (DeBusk et al., 2006). Wound healing is also 
promoted by wound dressings that are designed to 
keep the wound clean and free of contamination. 
Starch hydrolysate is a favorable dressing component 
because it facilitates the exposure of dermatological 
agents added to improve healing, assists in contacting 
all areas of the wound (Silvetti et al., 1997) and 
at the same time, provides topical nutrients to the 
wound site, creating a natural healing environment 
that promotes the growth of granulation tissue 
and epithelial proliferation. Hygroscopic starch 
hydrolysate creates a dehydrating environment due 
to the intramolecular hydrogen bonding in amylose, 
which kills bacteria and hastens wound healing 
(Moore et al., 2005). In fact, starch hydrolysate not 
only helps to eliminate infections but also contributes 
to cost saving by reducing the necessity for skin 
grafting and the overall cost of wound care.
Over the years, corn, potato, sago, tapioca and 
wheat starch has been widely used in commercial 
starch hydrolysate production. To date, full spectrum 
studies on the physico-chemical characteristics of 
starch hydrolysate produced from breadfruit starchy 
sources are lacking. Differences in the molecular 
structure of this breadfruit starch will affect the 
physico-chemical properties of breadfruit starch 
hydrolysate that will eventually define its specific 
functional application in wound healing. The aim of 
this study is to investigate the effects of breadfruit 
starch hydrolysate with different DE grade on the 
migratory behavior and wound healing rate of NIH 
3T3 cells, in the latter case using an in vitro wound 
healing scratch assay.
Materials and Methods
Preparation of breadfruit starch hydrolysate 
Mature but un-ripened breadfruit was purchased 
from a local market (Selangor, Malaysia). The starch 
was prepared at a laboratory scale (Akanbi et al., 
2009; Koh et al., 2012). The suspension of starch 
(20%) was prepared with 40 g starch to 200 mL of 
distilled water. An amount of 0.04 g calcium chloride 
was added. The pH was adjusted to 6.5 with sodium 
hydroxide (0.1 N) before hydrolyse using enzyme Ban 
480L. Different dextrose equivalent (DE) value of 
breadfruit starch hydrolysate was prepared according 
to the specific enzymatic hydrolysis process condition 
(MARDI in house method). Enzyme inactivation was 
done by adding hydrochloride acid (0.1 N) to achieve 
pH value of 3.0 before transferred to centrifuge 
to separate clear supernatant from crude starch 
hydrolysate under the condition of 4°C, 10,000 rpm 
for 10 mins. The liquid starch hydrolysate was spray 
dried using optimized parameter setting as studied 
earlier: inlet temperature (170°C); feed flow (9%) 
and aspirator rate (95%). A total of 10% commercial 
(COM) starch hydrolysate (cassava base, DE 10-14) 
was used as the reference material because it was 
known to be of high quality (Koh et al., 2012). A 
commercial wound dressing agent, Multidex (MUL) 
containing 99% predominantly sterile NF1 starch 
hydrolysate with 1% ascorbic acid was used for 
comparison purpose.
Determination of dextrose equivalent (DE) value
The Lane and Eynon method was used to analyze 
the DE value of breadfruit starch hydrolysate samples. 
Fehling Solutions were standardized against standard 
dextrose obtained from the Bureau of Standards. To 
determine the Fehling Factor, 0.5 g anhydrous grams 
of dextrose was weighed per 200 mL of distilled 
water and used as the test solution. Fehling Factor 
was calculated as follow: 
A starch hydrolysate solution (10 g/ 200 mL) 
with the known concentration of an anhydrous starch 
basis was prepared. The starch hydrolysate solution 
was transferred to a 50 mL burette. To 50 mL of 
distilled water in a 500 mL Erlenmeyer flask, 5 mL 
of each Fehling A and Fehling B were added in. The 
contents of the flask were brought to boil over a hot 
plate. When the water starts boiling, add in 2 drops 
of methylene blue indicator and stirred continuously. 
The titration was completed by adding the starch 
hydrolysate solution dropwise until the blue colour 
disappears. The volume of starch hydrolysate solution 
used was recorded. The DE was calculated based on 
below stated formula:
Determination of glucose polymer profiling using 
liquid chromatography-mass spectrometry (LC-MS)
LCMS experiment was performed on a Shimadzu 
LCMS 2020 coupled with an electrospray ion (ESI) 
source. The single stage quadruple mass spectrometer 
provides an upper mass unit limit of 2000 dalton. 
Nebulizer gas flow was 1.5 L/min and MS parameter 
setting was optimized to the following: detector 
voltage = 1 kV, CDL = 25V, DL temperature = 250°C 
and block temperature was 200°C.
Polyamine-bonded polymeric gel column 
(apHeraTM NH2, 25 cm x 4.6 mm, 5 µm) were used 
to separate different glucose polymer chain length of 
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starch hydrolysate with the controlled temperature of 
40°C. Mobile phase composition was consisted of 
acetonitrile (A) and 0.1% formic acid in water (B) and 
was conducted in the gradient mode: 0-3 min, 65% B; 
3-15 min, 10% B; 15-20 min, 10% B; 20-20.1 min, 
65% B and 20.1-25 min, 65% B with the flow rate of 
0.7 mL/min. The quantification of different glucose 
polymer chain length was done using calibration 
curves obtained by injecting known amount of each 
glucose polymer chain length standard with the 
known retention times. 
Culture of cell lines
NIH 3T3 cell line was obtained from ATCC 
(USA) and cultured in Roswell Park Memorial 
Institute (RPMI) 1640 medium supplemented with 
1% penicillin-streptomycin and 10% fetal bovine 
serum (FBS) in a humidified incubator with 5% carbon 
dioxide. The cell line was detached from culture flasks 
using a trypsin- Ethylenediaminetetraacetic acid 
(EDTA) solution (0.25-0.025%) and re-suspended 
as a single cell suspension in RPMI 1640 culture 
medium.
In vitro wound scratch assay and microscopy 
evaluation
NIH 3T3 cells were seeded in a tissue culture 
6-well plate at an initial density of 2.4 x 105 cells/
cm2 overnight. A micropipette tip was used to create a 
wound in the monolayer by scraping. A total of 10% 
(w/v) breadfruit starch hydrolysate was added in each 
treatment well with or without an addition of 100 ppm 
of various additives including aloe vera, curcumin, 
hydroxyproline, ascorbic acid, L-arginine, lactic 
acid and kojic acid, which were added separately 
into each well. Another two wells were treated with 
commercial wound dressing agent (MUL) and media 
only (control), respectively. Wound closure was 
observed by a phase-contrast microscopy (NIKON, 
Japan) and digital images were taken at the interval 
time of 3 h up to 24 h. The % of wound healing was 
calculated based on the length of wound measured at 
the specific time as described below:
whereby ‘0 hour’ indicates the length of which the 
wound was initially created and ‘Y hours’ represents 
the length of the wound measured at the specific time. 
Determination of NIH 3T3 cell viability via trypan 
blue cell count assay
Trypan blue cell count was carried out to 
identify the amount of viable cells present in each 
sample. Harvested cell suspension (10 µL) was 
added with equal volume of 0.4% trypan blue stain. 
Hemocytometer was used for cell counting under 
inverted light microscope (NIKON, Japan). Viable 
cells are those excluded from the stain.
5-bromo-2’-deoxyuridine (BrdU) ELISA cell 
proliferation assay
Starch hydrolysate treated and untreated NIH 
3T3 cell proliferation was measured using the 
Bromodeoxyuridine (BrdU) Cell Proliferation 
Kit (Merck, USA). The cells were seeded in a 96 
well plate at a concentration of 0.8 x 105 cells/ mL 
overnight. A total of 10% (w/v) breadfruit starch 
hydrolysate was added separately with or without 
the addition of 100 ppm of various additives, 
including aloe vera, curcumin and hydroxyproline 
and incubated for 24, 48 and 72 h, respectively at 
37°C and 5% CO2. Another two wells were treated 
with MUL and media only to serve as untreated 
control. After the corresponding period, BrdU label 
was added into all wells and incubated for another 24 
h.  At the respected incubation hours, the cells were 
fixed and incubated at 4°C for approximately 30 min. 
After that, the plates were washed twice before added 
with 100 µL detector antibodies into each well and 
incubated for 1 h. Then, 100 µL of Goat anti-mouse 
IgG-HRP conjugated was added and incubated for 
30 min. Then, the plates were incubated with 100 µL 
of 3, 3′, 5, 5′-Tetramethylbenzidine (TMB) substrate 
for another 30 min. Finally, 100 µL of stop solution 
(sulfuric acid) was added and the absorbance was 
measured at 450 nm, using an ELISA microplate 
reader (Biotech Instruments, USA).
3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl 
tetrazolium bromide (MTT) cell viability assay on 
NIH 3T3 cells
NIH 3T3 cells were seeded on 96 well microtiter 
plates overnight. An amount of 10% breadfruit starch 
hydrolysate was added in each treatment well. A total 
of 100 ppm of various additives including aloe vera, 
curcumin and hydroxyproline was added separately 
into each well. Both MUL and media were acted as 
a control. The fibroblast cells treated with various 
samples was exposed to the culture medium up to 
72 h.  At each interval time of 24 h, a total of 20 
µL/ well of MTT solution (Calbhiochem, USA) were 
added, followed by incubation at 37°C for a period 
of 4 h in an atmosphere of air with 5% CO2. After 
that, supernatants were removed from the wells and 
100 µL/well of dimethyl sulfoxide (DMSO) (Fisher, 
USA) were added to solubilize formazan. The 
absorbance was quantified at 570 nm using ELISA 
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microplate reader (Biotech Instruments, USA).
Cell cycle analysis
The cells were seeded in a 6-well plate at a density 
of 2.4 x 105 cells/ mL and were grown overnight. Then, 
the cells were treated with 5% (w/v) breadfruit starch 
hydrolysate, with or without the addition of 100 ppm 
of various additives, including aloe vera, curcumin 
and hydroxyproline, which were added separately. 
Another two wells were treated with MUL or culture 
medium, which served as the controls. After 24 h, the 
cells were trypsinized and washed using phosphate-
buffered saline (PBS). The cell pellets were fixed 
using 70% ethanol and were stored at -20°C. After a 
week, the fixed cells were washed with PBS, treated 
using a solution of RNase-A containing Triton-X and 
were stained using Propidium Iodide (PI). Finally, the 
cells were subjected to flow cytometry using a BD 
FACS Calibur instrument (Becton Dickinson, USA). 
All of the chemicals used in the cell-cycle analysis 
assay were purchased from Sigma (USA).
In vitro red blood cell (RBC) irritation assay
Approximately 2 mL of RBC obtained from a 
volunteer (Pusat Kesihatan, UPM) and was washed 
in PBS in a ratio of 1:10, followed by centrifuged for 
10 min at 1500 rpm with a controlled temperature of 
10°C and this step was repeated triplicate. The RBC 
was then diluted with PBS to a 1% concentration. 
Each 100 µL of breadfruit starch hydrolysate, COM 
starch hydrolysate and MUL were loaded into the 
first well in a 96 well-plate separately, followed by 
50 µL of PBS loaded from the 2nd to the 12th well. A 
serial dilution was carried out from the 1st well to the 
11th well and the 12th well was treated as the positive 
control. Then, a total of 50 µL of 1% RBC was added 
to each well before incubated at room temperature 
for 30 min. At the end of incubation, the suspension 
was centrifuged at 500 rpm at 10°C for 10 min.
Statistical analysis
Data was statistically analyzed by one-way 
analysis of variance (SPSS statistics version 16). 
Significant differences (p<0.01) between means were 
determined by Duncan’s multiple range test.
Results and Discussion
Determination of glucose polymer profiling using 
liquid chromatography-mass spectrometry (LC-MS)
In this study, liquid chromatography-mass 
spectrometry with electrospray was used to identify 
the glucose polymer profile of starch hydrolysate. 
Oligosaccharides are not easily ionized, therefore, 
combination of high acetonitrile mobile phase 
with 0.1% of formic acid in water is required to 
achieve better mass ion peaks. The retention of 
oligosaccharides in high acetonitrile-containing 
mobile phase on polyamine-bonded polymeric gel 
column (apHeraTM NH2) is based on the hydrogen 
bonding interaction between the hydroxyl groups of 
oligosaccharides and polyamine-bonded stationary 
phase. The gradient elution consisting of 100% 
acetonitrile and 0.1% formic acid in water with column 
temperature set at 40°C had successfully separated 
all the 7 mixtures of oligosaccharides standard 
(DP1 = glucose; DP2 = maltose; DP3 = maltotriose; 
DP4 = maltotetraose; DP5 = maltopentaose; DP6 = 
maltohexaose; DP7 = maltoheptaose). Table 1 shows 
the representative glucose polymer profiling of 
breadfruit starch hydrolysate from three different DE 
groups: a) DE 10-14; b) DE 15-19 and c) DE 20-24. 
The DE value is inversely related to molecular weight. 
It is an indicator of the degree of starch hydrolysis 
(Sun et al., 2010). Based on the data obtained, starch 
hydrolysate DE 20-24 contained the highest amount 
of smaller molecular structure of oligosaccharides 
ranging from DP 1 to DP 7, indicating the least 
amount of longer glucose chain length (DP > 7). DP 
Table 1. Glucose polymer profiling of breadfruit starch hydrolysate
aEach data was expressed as mean ± standard deviation of triplicate determinations. Mean 
values with different superscripts in the same column are significantly different p<0.01.
(Abbreviations: BB = breadfruit starch hydrolysate; DE=dextrose equivalent; DP1=Glucose; 
DP2 = Maltose; DP3= Maltotriose; DP4 = Maltotetraose; DP5, Maltopentaose; DP6 = 
Maltohexaose; DP7 = Maltoheptaose)
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1-7 was the total oligosaccharides with smaller chain 
length of sugar molecules (from glucose DP1 up to 
maltoheptoase DP7), while DP > 7 was the glucose 
molecule chain length longer than maltoheptaose. 
The characteristics of breafruit starch hydrolysate 
DE 20-24 resulted in a more viscous solution as it 
contained higher sugar composition compared to 
starch hydrolysate DE 10-14 and 15-19. Based on 
Dokic et al. (2004) study, the viscosity increases with 
the increasing DE value of the starch hydrolysate, 
because the percentage of saccharides with lower 
degree of polymerization in the mixture is higher. 
The difference in sugar composition between starch 
hydrolysate with different DE ranges (DE 10-14, DE 
15-19 and DE 20-24) is believed to have caused an 
effect on their role in the wound healing of NIH 3T3 
cells process. Because of that, a wound healing study 
was conducted to analyze the NIH 3T3 wounded cell 
migratory rate in in vitro wound healing study using 
different grades of breadfruit starch hydrolysate DE 
to proof this statement.
Evaluation of different DE grades of breadfruit starch 
hydrolysate effect on wound closure rate via in vitro 
wound healing of NIH 3T3 cells assay
In vitro wounding of a confluent monolayer 
initiates cells to start migrating and proliferating at 
the edge of the wounds (Schreier et al., 1993). Table 
2 shows the results of in vitro wound healing of NIH 
3T3 cells treated with breadfruit starch hydrolysate 
DE 10-14, 15-19 and 20-24 with or without the 
addition of 100 ppm selected additives. The selected 
additives including curcumin, hydroxyproline, 
ascorbic acid, L-arginine, lactic acid and kojic acid 
were chosen based on previous reports of their 
significant wound healing properties (Choi et al., 
2006; Panchatcharam et al., 2006; Debats et al., 2009; 
Hansen et al., 2009; Wu et al., 2011; Hussein et al., 
2012). The use of aloe vera in wound healing is being 
considered in many studies. Aloe vera is known to 
contain anthraquinones, saccharides, vitamin E and 
C, zinc, enzymes, acetyl salicyclic and others (Reddy 
et al., 2011). A major carbohydrate fraction obtained 
from the aloe vera leaf is called, acemannan, which 
is the key promoter of wound healing (Reddy et al., 
2011). A study conducted by Maenthaisong et al. 
(2007) reported that burn healings were 8.79 days 
faster than those in the control group when treated 
with topical aloe vera. Therefore, the proliferation 
effect of breadfruit starch hydrolysate with addition 
of 100 ppm aloe vera on wounded NIH 3T3 cells was 
examined in the proceeding analysis. According to 
Schreier et al. (1993), compared with that of cells in 
the absence of the additive, the addition of an additive 
(platelet-derived growth factor) notably increased the 
rate of cell migration to the ‘wounded’ area. MUL, 
one of the commonly utilized commercial wound 
dressings was used as a negative control. 
Based on the results obtained in Table 2, 
breadfruit starch hydrolysate with a DE range of 
10-14 possessed significantly (p<0.01) the highest 
rate of wound healing in relative to breadfruit starch 
hydrolysate DE 15-19 and DE 20-24 ranges. As starch 
hydrolysate is a product of low hydrolysis degree, it 
Table 2. The percentage of wound closure by NIH 3T3 cells treated with 10% breadfruit 
starch hydrolysate (BB) DE 10-14, DE 15-19 or DE 20-24 with or without the addition 
of 100 ppm of various additives
aEach data was expressed as mean ± standard deviation of triplicate determinations. Mean values 
with different superscripts in the same column are significantly different p<0.01. Mean values with 
different superscripts in the same row are significantly different p<0.01
(Abbreviations: BB: Breadfruit starch hydrolysate; CUR: Curcumin; HYD: Hydroxyproline; AA: 
Ascorbic acid; ARG: L-Arginine; LA: Lactic acid; KA: Kojic acid; MUL; commercial wound 
dressing agent; CTRL: Control)
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still contains high percentage of highly polymerized 
saccharides (Dokic et al., 2004). The DE value of 
starch hydrolysate will affect the viscosity, sugar 
composition and its characteristics (Moore et al., 
2005). According to a study conducted by Dokic et al. 
(2004) to determine the characteristics of different DE 
of starch hydrolysate, it was shown that the viscosity 
of starch hydrolysis increases with the increment of 
DE value, because the percentage of saccharides with 
low degree of polymerization in the mixture is higher. 
The latter statement explains the poor performance of 
breadfruit starch hydrolysate in both DE 15-19 and 
DE 20-24 treatments. The high DE values (DE 15-19 
and 20-24) of breadfruit starch hydrolysate exhibited 
viscous and contain more concentrated of smaller 
molecular structure sugar which reduced the ability 
of cell migration and thus decreased the ability of the 
starch hydrolysate to diffuse into the cell monolayer 
(Swaim et al., 1998). Breadfruit starch hydrolysate 
with a lower DE value is preferable to facilitate the 
exposure of dermatological agents added to improve 
the healing and facilitates the contact to all areas of 
the wound (Silvetti et al., 1993).
The addition of 100 ppm additives were seen to 
improve the percentage of wound closure compared 
to media alone. Nevertheless, breadfruit starch 
hydrolysate DE 10-14 alone had significantly shown 
the best recovery rate (p<0.01) in wound healing 
compared to other treatments with addition of various 
additives. The purpose of adding various types of 
additives is only meant to compare their healing 
effects with our breadfruit starch hydrolysate. Based 
on our findings, breadfruit starch hydrolysate DE 
10-14 possessed the best criteria as a wound healing 
agent and confirmed its effectiveness to facilitate the 
wound healing process of NIH 3T3 cells.
To further investigate the wound healing activity 
of breadfruit starch hydrolysate on NIH 3T3 cell 
wounds, a commercial (COM) starch hydrolysate 
obtained from cassava was studied under the same 
conditions. Cassava base was selected because it is a 
high quality starch hydrolysate that is widely used in 
food and pharmaceutical applications. A comparative 
study of breadfruit and cassava starches by Koh et 
al. (2012) demonstrated differences in their physico-
chemical properties that would affect the functional 
properties of the starch hydrolysates produced from 
the hydrolysis of different starchy sources.  
Figure 1a shows the wound healing performance 
of breadfruit starch hydrolysate, commercial starch 
hydrolysate (COM) and commercial dressing 
agent (MUL). The graph shows that the percentage 
of wound closure by NIH 3T3 cells treated with 
breadfruit starch hydrolysate was the highest, 
followed by COM starch hydrolysate. Whereas, the 
commercial dressing agent (MUL) had caused death 
to the NIH 3T3 cell (Figure 1b). Although breadfruit 
and COM starch hydrolysate shared similar range 
of DE values (10-14), the time necessary for wound 
closure significantly varied (p<0.01)  depending on 
the source of the starch hydrolysate. Our finding is 
consistent with the result described earlier showing 
that starch hydrolysate with the same range of DE 
values obtained from different starchy sources 
have different functional and physico-chemical 
properties that are highly dependent on the starch 
molecular structure (Moore et al., 2005; Sun et 
al., 2010). As reported herein, breadfruit starch 
hydrolysate stimulated the proliferation of NIH 3T3 
cells significantly better (p<0.01) than did COM 
starch hydrolysate. One of the possible explanations 
for the less efficient performance of COM starch 
hydrolysate in wound healing relative to breadfruit 
starch hydrolysate is its size. According to Koh et 
al. (2012), as shown using microscopy, cassava 
starch exhibited the largest molecule size compared 
aThe values were expressed as the mean values ± standard 
deviation of triplicate determinations. The mean values indicated 
using different superscript letters were significantly different at 
p<0.01
(Abbreviations: BB: breadfruit starch hydrolysate; COM: 
commercial starch hydrolysate; MUL: commercial wound 
dressing)
Figure 1. Results of the in vitro scratch assays of NIH 3T3 
fibroblasts treated using starch hydrolysates obtained from 
different sources: a) % wound closure; b) image of wound 
closure between BB starch hydrolysate DE 10-14 and 
MUL  sample at 0 hour and 24 hours
Amin et al./IFRJ 24(4): 1771-1781 1777
with that of breadfruit starches. The larger size 
of COM starch hydrolysate molecules may have 
led to a poor nutrient distribution to the NIH 3T3 
cells, thus restricting the rate of migration. Overall, 
breadfruit starch hydrolysates were clearly shown 
to positively affect wound healing, substantiating 
their utility as wound healing agents. In this study, 
we demonstrated that breadfruit starch hydrolysate 
performed significantly better (p<0.01) than COM 
starch hydrolysate as a wound healing agent.  
Based on the positive results obtained from 
breadfruit starch hydrolysate with low DE range (DE 
10-14) compared to the high DE starch hydrolysates 
(DE 15-19 and 20-24), several assays were conducted 
on breadfruit starch hydrolysate DE 10-14 to further 
analyze its efficacy on NIH 3T3 cell proliferation and 
viability.
Determination of NIH 3T3 cell viability via trypan 
blue cell count assay
Determination of cell viability is a well-recognized 
requirement of most biological investigations using 
cellular preparations (Medzihradsky et al., 1975). 
Trypan blue is one of the most widely applied methods 
used to demonstrate cell viability in the exclusion of 
dyes (Medzihradsky et al., 1975). Trypan blue is a vital 
dye containing a negatively charged chromopore that 
enter cells when the plasma membrane is damaged 
(Freshney et al., 1987). Therefore, cells that exclude 
this dye are considered viable. 
Figure 2 shows the results of the trypan blue 
viability assay of NIH 3T3 cells treated with 
breadfruit starch hydrolysate (DE 10-14) that was 
conducted to determine the percentage of viable 
cells present during the in vitro wound healing study. 
The results of the trypan blue viability assay were 
consistent with the percentage of wound closure 
obtained as discussed earlier. It was found that a 
higher percentage of viable cells supported the 
treatments that showed better improvement in the 
wound closure rate.  
aThe values were expressed as the mean values ± standard 
deviation of triplicate determinations. The mean values indicated 
using different superscript letters were significantly different at 
p<0.01
(Abbreviations: BB: breadfruit starch hydrolysate; CUR: 
curcumin; HYD: hydroxyproline; AA: ascorbic acid; LAR: 
L-arginine; LA: lactic acid; KA: kojic acid; MUL: commercial 
wound dressing; COM: commercial starch hydrolysate; CTRL: 
control)
Figure 2. The percentage of viable cells treated breadfruit 
starch hydrolysate (DE 10-14) with 100 ppm of various 
additives
aThe values were expressed as the mean values ± standard 
deviation of triplicate determinations. The mean values indicated 
using different superscript letters were significantly different at 
p<0.01
(Abbreviations: BB: breadfruit starch hydrolysate; AV: Aloe 
vera extract; CUR: curcumin; HYD: hydroxyproline; COM: 
commercial maltodextrin; MUL: commercial wound dressing)
Figure 3. Results of: a) BrdU-based cell proliferation 
assay; b) MTT-based cell viability assay; c) cell-cycle 
analysis of various treatment group on NIH 3T3 fibroblast 
cell; d) In vitro red blood cell hemolysis assay conducted 
using various starch hydrolysates
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Based on the counts of viable cells, 100% of all 
starch hydrolysate-treated populations were viable, 
except for those treated with additives such as lactic 
acid, L-arginine and kojic acid (BBLA, BBLAR 
and BBKA) respectively which only exhibited 93-
95% cell viability count. These findings indicated 
that the presence of lactic acid, L-arginine and kojic 
acid affected the viability of NIH 3T3 fibroblasts. 
Although breadfruit starch hydrolysate alone were 
found to improve wound healing more than did these 
substances in the presence of additives, most of the 
cells treated with additives maintained 100% cell 
viability. It was found that cells treated with MUL, a 
commercial wound dressing were killed (Figure 1b & 
2). This finding indicated that the presence of MUL 
most likely had caused substantial cellular damage 
over time, leading to the death of the cells (Guenoun 
et al., 2005). Generally, the results of the trypan blue 
viability assay had supported the wound healing 
capability of breadfruit starch hydrolysate with a DE 
value of 10-14, as shown by the percentage of wound 
closure in NIH 3T3 cells. 
BrdU ELISA cell proliferation assay
A BrdU-based cell proliferation ELISA was 
used to evaluate the effect of starch hydrolysate on 
the proliferation of NIH 3T3 fibroblast cells in vitro. 
Cultured cells that entered the log growth phase 
were pulsed labeled using non-radioactive BrdU 
(Klein et al., 2000). The results of the BrdU-based 
cell proliferation assay of NIH 3T3 cells treated with 
breadfruit starch hydrolysate with or without additives 
are shown in Figure 3(a). Generally, the proliferation 
rate of NIH 3T3 cells treated with breadfruit starch 
hydrolysate was noted increased gradually across 
incubation time compared to the controlled cells, 
except for COM and MUL treatment, whereby the 
percentage of cell proliferation of both COM and 
MUL treatment decreased significantly (p<0.01) 
from 24 to 72 h. The drastic decrease in cells treated 
with MUL when compared to the controlled cells is 
supported by the study of Guenoun et al. (2005); the 
preservatives presents in MUL may have contributed 
to its cytotoxic effect on NIH 3T3 cells. 
Overall, all of the NIH 3T3 fibroblast cells 
(except those treated with COM and MUL) 
achieved the highest rate of cell proliferation after 
72 h of incubation. The increase in the percentage 
of proliferating fibroblasts may be attributed to the 
stimulatory effect of starch hydrolysate with DE 
value of 10-14. This conclusion was reached by 
Coolen et al. (2010) in their comparative study using 
a tissue model to determine the best wound healing 
performance by observing the most effective tissue 
model through increase in the rate of fibroblast 
proliferation via BrdU incorporation. 
Cells treated with breadfruit starch hydrolysate 
with or without additives showed a higher 
rate of proliferation than the control group. In 
general, the highest rate of cell proliferation at 
72 h was achieved by treatment with breadfruit 
starch hydrolysate, which was 48.21% higher 
in proliferation compared to the control group, 
followed by breadfruit starch hydrolysate with 
100 ppm curcumin (21.26%), breadfruit starch 
hydrolysate with 100 ppm hydroxyproline (8.49%) 
and breadfruit starch hydrolysate with 100 ppm aloe 
vera extract (6.47%). Compared with the effect of 
COM starch hydrolysate obtained from cassava, 
our newly developed breadfruit-derived starch 
hydrolysate was found capable to promote higher 
cell proliferation rate, confirming the other findings 
that indicated their superior functional properties for 
wound healing applications. In brief, the percentage 
of cells proliferating treated with breadfruit starch 
hydrolysate alone was significantly (p<0.01) higher 
than that observed using others treatments. The 
higher proliferation rate of NIH 3T3 cells treated 
with the starch hydrolysates may be attributed to 
their glucose content, which supplied energy for the 
metabolism and proliferation of cells (Swaim et al., 
1998). These findings indicated that wounded NIH 
3T3 cells treated with starch hydrolysate received 
enough nutrient supply, effectively improved their 
cell proliferation rate compared with that of the 
untreated cells.
MTT cell viability assay on NIH 3T3 cells
A MTT assay was performed to evaluate the 
viability of NIH 3T3 cells treated with breadfruit 
starch hydrolysate. This test involves the conversion 
of a tetrazolium salt, 3-(4, 5-dimethylthiazol-2-
yl)-2, 5 diphenyl tetrazolium bromide (MTT) to an 
insoluble formazan product, which is quantitated 
using spectrophotometry (Klein et al., 2000). Figure 
3(b) presents the result of NIH 3T3 cell viability 
assay treated with breadfruit starch hydrolysate at 
10% of concentration, with or without the addition 
of 100 ppm of additives. Generally, the viability rates 
of cells treated with breadfruit starch hydrolysate 
at concentration of 10% was observed significantly 
increased (p<0.01) with the treatment period. The 
increase in the cell viability rate indicated that the 
cells remained viable even after treatments of up to 
72 h. The same phenomenon observed in the BrdU-
based proliferation assay, the results of the MTT-
based viability assay showed a significant decreased 
(p<0.01) in the percentage of viable cells in the 
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MUL-treated group at 24, 48 and 72 h of exposure. 
The toxicity effect of 72 h treatment with 10% MUL 
decreased the percentage of viable cells from 53.85% 
to 44.83%. 
Briefly, NIH 3T3 cell treated with 10% breadfruit 
starch hydrolysate were found to have the highest 
percentage of viable cells at 72 h of exposure 
(154.79%), followed by breadfruit starch hydrolysate 
with 100 ppm hydroxyproline (135.21%), breadfruit 
starch hydrolysate with 100 ppm curcumin (135.11%), 
COM starch hydrolysate (120.96%) and breadfruit 
starch hydrolysate with 100 ppm aloe vera extract 
(119.36%). Similar to the findings obtained using 
the BrdU-based cell proliferation assays, treatment 
with breadfruit starch hydrolysate alone resulted in 
the higher cell viability compared with that observed 
using the other treatments.
Cell cycle analysis using flow cytometry
Based on the above described results of the wound 
healing and cell proliferation studies, treatment with 
commercial wound dressing (MUL) was found failed 
to promote the healing of wounded NIH 3T3 cells. It 
was important to identify whether the concentration 
of MUL used was the main factor causing the death 
of these cells. Therefore, flow cytometric cell cycle 
analysis was conducted to evaluate the effect of 
5% breadfruit starch hydrolysate with or without 
100 ppm of additives relative to that of same 
concentration of MUL on the cell cycle progression 
of NIH 3T3 cells. Figures 3(c) shows the cell cycle 
distribution of NIH 3T3 cells treated with 5% of both 
MUL and breadfruit starch hydrolysate respectively. 
The results showed that NIH 3T3 cells treated with 
MUL, even at a very low concentration, exhibited 
a drastic increased in the sub G0/G1 population, 
indicating that MUL induced DNA fragmentation 
(Guenoun et al., 2005). The sub G0/G1 population 
was 54.40%, while the population was reduced in the 
S and G2/M phases, at 5% concentration of MUL. 
In contrast, 5% breadfruit starch hydrolysate with or 
without additives increased the cell population which 
is undergoing DNA synthesis. This finding confirmed 
that prolonged exposure to MUL was toxic to the 
cells, consistent with the earlier findings in MTT cell 
viability assay that confirmed that MUL was not a 
good in vitro wound healing agent, as demonstrated 
using the in vitro wound healing model.
In vitro red blood cells (RBCs) irritation assay
The development of a number of in vitro methods 
to reduce the use of animals were reviewed recently 
due to the criticism regarding the use of classical 
in vivo methods to determine whether a substance 
causes skin or ocular irritation (Benavides et al., 
2004). An in vitro irritation assay employing RBCs 
is a good alternative to the in vivo eye-irritation 
test because it is an inexpensive, rapid method that 
provides reliable results with good reproducibility 
and reduces or avoids the use of experimental 
animals (Lagarto et al., 2006). The tested sample is 
assumed not to irritate cells and thus confirm to be 
safe for human use on skin if the RBCs remain intact 
and maintain their normal shape. Lysis of the RBCs 
indicates that the sample at the tested concentration 
had an irritation effects.
In this study, a RBCs hemolysis assay was 
conducted using various concentrations of BB 
starch hydrolysate, COM starch hydrolysate and 
MUL. Wells containing either PBS or RBCs served 
as positive controls. When the starch hydrolysate 
was added to erythrocytes suspended in an aqueous 
medium, the molecules were distributed between 
the erythrocyte membranes and the solution by 
absorption until an equilibrium was reached (Mitjans 
et al., 2003). Hemolysis most likely began when 
the erythrocyte membranes were saturated with the 
treatment molecules (Mitjans et al., 2003). Based 
on the results in figure 3(d), none of treatments had 
hemolytic activity. This finding demonstrated that 
the starch hydrolysate were safe for topical use and 
would not irritate the human skin. MUL also did not 
cause RBC lysis although it caused cell death in the 
in vitro wound healing assay. The presence of the 
preservatives in MUL reduced the viability of NIH 
3T3 cells. This finding showed that the preservatives 
in MUL are safe to use on human skin but exhibit not 
safe for oral consumption or injection onto the skin. 
In summary, BB starch hydrolysate is confirmed to 
be safe and have shown no hemolytic effect on RBCs 
even at a high concentration.
Conclusion
Breadfruit starch hydrolysate with low DE 
values (DE 10-14) did improve the rate of wound 
closure better than their high DE counterparts (DE 
15-19 & DE 20-24), as demonstrated in an in vitro 
wound healing model. Interestingly, treatments with 
breadfruit starch hydrolysate of low DE values in 
the absence of additives resulted in the best rate of 
wound healing, as shown in the wound scratch assay, 
the trypan blue assay, the MTT cell viability assay, 
BrdU-based cell proliferation assay and the cell 
cycle analysis when compared with those treatments 
in the presence of additives. The breadfruit starch 
hydrolysate exhibited higher healing efficacy 
compared with that of COM starch hydrolysate, as 
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confirmed in the wound healing, MTT-based cell 
viability BrdU-based cell proliferation assays and 
cell cycle analysis. Most importantly, breadfruit 
starch hydrolysate did not induce any irritation effect 
as demonstrated in the RBCs assay. In conclusion, 
breadfruit starch hydrolysate is shown to have a 
positive effect on the rate of in vitro wound closure 
and could play a beneficial role in wound healing 
application.
Acknowledgements
We gratefully appreciate the financial support 
of this work by Ministry of Science, Technology 
and Innovation of Malaysia (06-03-08-SF0320). 
We would like to thank the staffs of the Institute of 
Bioscience, University Putra Malaysia (UPM) and 
Malaysian Agricultural Research and Development 
Institute (MARDI) for their help and the use of all 
facilities needed to conduct this study.
References
Akanbi, T.O., Nazamid, S. and Adebowale, A.A. 2009. 
Functional and pasting properties of a tropical 
breadfruit (Artocarpus altilis) starch from Ile-Ife, 
Osun State, Nigeria. International Food Research 
Journal 16: 151-157.
Benavides, T., Martı́nez, V., Mitjans, M., Infante, 
M.R., Moran, C., Clapés, P. and Vinardell, M.P. 
2004. Assessment of the potential irritation and 
photoirritation of novel amino acid-based surfactants 
by in vitro methods as alternative to the animal tests. 
Toxicology 201: 87-93.
Choi, C.M. and Berson, D.S. 2006. In Seminars in 
cutaneous medicine and surgery. Cosmeceuticals 25: 
163-168.
Coolen, N.A., Schouten, K.C., Boekema, B.K., 
Middelkoop, E. and Ulrich, M.M. 2010. Wound 
healing in a fetal, adult, and scar tissue model: a 
comparative study. Wound Repair and Regeneration 
18: 291-301.
Debats, I.B.J.G., Wolfs, T.G.A.M., Gotoh, T., Cleutjens, 
J.P.M., Peutz-Kootstra, C.J. and Van der Hulst, 
R.R.W.J. 2009. Role of arginine in superficial wound 
healing in man. Nitric Oxide 21: 175-183.
Debusk, V., Autry, O. and Alleman, T. 2004. Infused 
wound care dressings. US Patent 20040001878.
Dokic, L., Jakovljevic, J. and Dokic, P. 2004. Relation 
between viscous characteristics and dextrose 
equivalent of maltodextrins. Starch-Starke 56: 520-
525.
Freshney, R. 1987. Culture of Animal Cells: A Manual of 
Basic Technique. Alan R., p.117. New York: Wiley-
Liss Inc.
Gbadamosi, S.O. and Oladeji, B.S. 2013. Comparative 
studies of the functional and flavor-chemical properties 
of isolated Cassava, Cocoyam and Breadfruit starches. 
International Food Research Journal 20: 2273-2277.
Guenoun, J.M., Baudouin, C., Rat, P., Pauly, A., 
Warnet, J.M. and Brignole-Baudouin, F. 2005. In 
vitro study of inflammatory potential and toxicity 
profile of latanoprost, travoprost, and bimatoprost 
in conjunctiva-derived epithelial cells. Investigative 
Ophthalmology and Visual Science 46: 2444-2450.
Hansen, J.E. and Jespersen, L.K. 2009. Wound or tissue 
dressing comprising lactic acid bacteria. European 
Patent 2125046.
Haubner, F., Ohmann, E., Pohl, F., Strutz, J. and Gassner, 
H.G. 2012. Wound healing after radiation therapy: 
Review of the literature. Radiation Oncology 7: 162.
Hussein, H.K., Elnaggar, M.H. and Al-Dailamy, J.M. 
2012. Protective role of Vitamin C against hepatorenal 
toxicity of fenvalerate in male rats. Global Advanced 
Research. Journal of Environmental Science and 
Health Toxic 1: 60-65.
Klein, C.L., Wagner, M., Kirkpatrick, C.J. and Van Kooten, 
T.G. 2000. A new quantitative test method for cell 
proliferation based on detection of the Ki-67 protein. 
Journal of Materials Science: Materials in Medicine 
11: 125-132.
Koh, S.P. and Long, K. 2012. Comparison of physical, 
chemical and functional properties of broken rice and 
breadfruit starches against cassava starch. Journal of 
Tropical Agriculture and Food Science 40: 211-219.
Lagarto, A., Vega, R., Vega, Y., Guerra, I. and González, 
R. 2006. Comparative study of red blood cell method 
in rat and calves blood as alternatives of Draize eye 
irritation test. Toxicology in Vitro 20: 529-533.
Maenthaisong, R., Chaiyakunapruk, N., Niruntraporn, S. 
and Kongkaew, C. 2007. The efficacy of aloe vera 
used for burn wound healing: a systematic review. 
Burns 33: 713-718.
Mahmood, S., Abdel-Hameed, E.S.S., Bazaid, S.A., Al-
Shamrani, M.G. and Mohamed, H.F. 2014. Liquid 
chromatography-mass spectrometry (LC-MS) method 
for the determination of sugars in fresh pomegranate 
fruit juices. Der Pharma Chemica 6: 320-333.
Medzihradsky, F. and Marks, M.J. 1975. Measures of 
viability in isolated cells. Biochemical Medicine 13: 
164-177.
Mitjans, M., Martínez, V., Clapés, P., Pérez, L., Infante, 
M.R. and Vinardell, M.P. 2003. Low potential ocular 
irritation of arginine-based gemini surfactants and their 
mixtures with nonionic and zwitterionic surfactants. 
Pharmaceutical Research 20: 1697-1701.
Moore, G.R.P., Canto, L.R.D., Amante, E.R. and Soldi, 
V. 2005. Cassava and corn starch in maltodextrin 
production. Química Nova 28: 596-600.
Panchatcharam, M., Miriyala, S., Gayathri, V.S. and 
Suguna, L. 2006. Curcumin improves wound healing 
by modulating collagen and decreasing reactive 
oxygen species. Molecular and Cellular Biochemistry 
290: 87-96.
Reddy, C.U., Reddy, K.S. and Reddy, J.J. 2011.  Aloe 
vera-A wound healer. Asian Journal of Oral Health 
and Allied Sciences 1: 91.
Amin et al./IFRJ 24(4): 1771-1781 1781
Schreier, T., Degen, E. and Baschong, W. 1993. Fibroblast 
migration and proliferation during in vitro wound 
healing. Research in Experimental Medicine 193: 
195-205.
Silvetti, A.N. 1993. Mechanisms involved in wound 
healing.  Federation of American Societies for 
Experimental Biology Journal 3: 1251-5956.
Sun, J., Zhao, R., Zeng, J., Li, G. and Li, X. 2010. 
Characterization of Destrins with Different Dextrose 
Equivalents. Molecules 15: 162-5173.
Swaim, S.F. and Gillette, R.L. 1998. An update on 
wound medications and dressings. Compendium of 
Continuing Education in Dentistry 20: 1133-1144.
Wang, Y.J and Wang, L. 2000. Structures and Properties 
of Commercial Maltodextrins from Corn, Potato, and 
Rice Starches. Research Paper 52: 296-304.
Wu, G., Bazer, F.W., Burghardt, R.C., Johnson, G.A., Kim, 
S.W., Knabe, D.A. and Spencer, T.E. 2011. Proline and 
hydroxyproline metabolism: implications for animal 
and human nutrition. Amino Acids 40: 1053-1063.
Zerega, N.J., Ragone, D. and Motley, T.J. 2004. Complex 
origins of breadfruit (Artocarpus altilis, Moraceae): 
implications for human migrations in Oceania. 
American Journal of Botany 91: 760-766. 
